Scholars Central

Conference abstractPublished 29 Sep 2016

A scFv antibody targeting common oligomeric epitope has potential for treating several amyloidoses

Authors: Xiao-lin Yu

Chinese Academy of Sciences, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Overproduction or poor clearance of amyloids lead to amyloid aggregation and even amyloidosis development. Different amyloids may interact synergistically to promote their aggregation and accelerate pathology in amyloidoses. Amyloid oligomers assembled from different amyloids share common structures and epitopes, and are considered the most toxic species in the pathologic processes of amyloidoses, which suggests that an agent targeting the common epitope of toxic oligomers could provide benefit to several amyloidoses. Here we firstly showed that an oligomer-specific single-chain variable fragment antibody, W20 simultaneously attenuated motor and cognitive decline in Parkinson’s disease and Huntington’s disease mouse models, and ameliorated neuropathology by reducing α-synuclein and mutant huntingtin protein aggregate load and preventing synaptic degeneration. Neuroinflammation and oxidative stress in vivo were also markedly attenuated. The proposed strategy targeting the common epitopes of amyloid oligomers presents promising potential for treating Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, and other amyloidoses.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Xiao-lin Yu”